Abstract
Much has changed since the launch of The Lancet Rheumatology in 2019; since early 2020, the world has been gripped by the COVID-19 pandemic, a crisis that has seen rheumatology and rheumatologists rise to the forefront of cross-specialty collaborations, clinical trials, and front-line patient care. Despite the challenges of a global pandemic, robust research and trials on rheumatic and musculoskeletal conditions have forged ahead. To highlight some of the latest research in the field, The Lancet Rheumatology is planning to publish late-breaking content to coincide with the Annual European Congress of Rheumatology (EULAR 2021), which will be held virtually on June 2–5, 2021. We welcome high-quality submissions across all areas of rheumatology and musculoskeletal disease, particularly clinical trials and research that will change clinical practice or current thinking. We are also keen to see submissions that bridge specialities; those in which traditional rheumatic and musculoskeletal diseases might overlap with and reciprocally inform other conditions, as has been so powerfully demonstrated for COVID-19. The journal has a rigorous fast-track peer review process for original research, which reflects our belief in the timely dissemination of high-quality data to the community. If you are presenting your research at EULAR 2021, we can time publication to your presentation. Please submit your paper through our online submission system mentioning this call for papers in your covering letter. The deadline for submissions is Friday, March 12, 2021. We look forward to receiving your research submissions and continuing to work alongside you to advance the field of rheumatology and help improve the lives of patients. For EULAR 2021 see https://congress.eular.org/To submit a manuscript to The Lancet Rheumatology go to https://www.editorialmanager.com/tlrheu/default.aspx For EULAR 2021 see https://congress.eular.org/ To submit a manuscript to The Lancet Rheumatology go to https://www.editorialmanager.com/tlrheu/default.aspx
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have